Latest Insider Transactions at Alx Oncology Holdings Inc (ALXO)
This section provides a real-time view of insider transactions for Alx Oncology Holdings Inc (ALXO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALX ONCOLOGY HOLDINGS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALX ONCOLOGY HOLDINGS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2024
|
Rekha Hemrajani |
BUY
Open market or private purchase
|
Direct |
30,000
+47.62%
|
$30,000
$1.55 P/Share
|
|
Aug 14
2024
|
Shelly Pinto Interim CFO |
SELL
Open market or private sale
|
Direct |
564
-0.61%
|
$1,128
$2.58 P/Share
|
|
Aug 14
2024
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,191
-1.28%
|
$4,382
$2.58 P/Share
|
|
Aug 14
2024
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
1,937
-0.33%
|
$3,874
$2.58 P/Share
|
|
Aug 14
2024
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
761
-0.62%
|
$1,522
$2.58 P/Share
|
|
Aug 14
2024
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,365
-0.42%
|
$2,730
$2.58 P/Share
|
|
Jul 11
2024
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
20,000
-3.26%
|
$140,000
$7.9 P/Share
|
|
Jul 11
2024
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.16%
|
$0
$0.99 P/Share
|
|
Jul 05
2024
|
Shelly Pinto Interim CFO |
SELL
Open market or private sale
|
Direct |
1,823
-1.94%
|
$9,115
$5.5 P/Share
|
|
Jul 01
2024
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
10,758
-1.78%
|
$53,790
$5.82 P/Share
|
|
Jul 01
2024
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,273
-0.99%
|
$16,365
$5.82 P/Share
|
|
Jul 01
2024
|
Shelly Pinto Interim CFO |
SELL
Open market or private sale
|
Direct |
1,373
-1.44%
|
$6,865
$5.82 P/Share
|
|
Jun 28
2024
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,789
-1.44%
|
$10,734
$6.03 P/Share
|
|
Jun 13
2024
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
12,000
+8.93%
|
$96,000
$8.53 P/Share
|
|
Jun 04
2024
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
20,000
-3.2%
|
$160,000
$8.43 P/Share
|
|
Jun 04
2024
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.1%
|
$0
$0.99 P/Share
|
|
May 13
2024
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-1.76%
|
$192,000
$16.25 P/Share
|
|
May 06
2024
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
20,000
-3.2%
|
$300,000
$15.92 P/Share
|
|
May 06
2024
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.1%
|
$0
$0.99 P/Share
|
|
Apr 16
2024
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
50,000
-7.64%
|
$700,000
$14.2 P/Share
|
|
Apr 16
2024
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,846
+3.8%
|
$0
$0.99 P/Share
|
|
Apr 04
2024
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
20,000
-3.08%
|
$220,000
$11.15 P/Share
|
|
Mar 14
2024
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
4,400
+2.5%
|
$48,400
$11.31 P/Share
|
|
Feb 14
2024
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.47%
|
-
|
|
Feb 14
2024
|
Shelly Pinto Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+13.81%
|
-
|
|
Feb 14
2024
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+8.06%
|
-
|
|
Feb 14
2024
|
Jaume Pons PRESIDENT & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+4.42%
|
-
|
|
Feb 14
2024
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+26.41%
|
-
|
|
Jan 04
2024
|
Shelly Pinto Interim CFO |
SELL
Open market or private sale
|
Direct |
2,717
-3.34%
|
$35,321
$13.6 P/Share
|
|
Dec 29
2023
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,128
-0.99%
|
$46,920
$15.04 P/Share
|
|
Dec 29
2023
|
Shelly Pinto Interim CFO |
SELL
Open market or private sale
|
Direct |
1,631
-1.97%
|
$24,465
$15.04 P/Share
|
|
Dec 29
2023
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,893
-2.17%
|
$28,395
$15.04 P/Share
|
|
Dec 29
2023
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
7,179
-1.15%
|
$107,685
$15.04 P/Share
|
|
Jul 25
2023
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+9.73%
|
-
|
|
Jul 25
2023
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+26.95%
|
-
|
|
Jul 25
2023
|
Shelly Pinto Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
26,000
+24.14%
|
-
|
|
Jul 25
2023
|
Jaume Pons PRESIDENT & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
89,000
+12.46%
|
-
|
|
Jul 06
2023
|
Shelly Pinto Interim CFO |
SELL
Open market or private sale
|
Direct |
7,345
-11.65%
|
$44,070
$6.52 P/Share
|
|
Jun 30
2023
|
Shelly Pinto Interim CFO |
SELL
Open market or private sale
|
Direct |
466
-0.73%
|
$3,262
$7.34 P/Share
|
|
Jun 30
2023
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
3,208
-0.59%
|
$22,456
$7.34 P/Share
|
|
Jun 30
2023
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,605
-0.57%
|
$11,235
$7.34 P/Share
|
|
Jun 30
2023
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
887
-1.59%
|
$6,209
$7.34 P/Share
|
|
Jun 09
2023
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,829
+1.51%
|
$38,487
$3.6 P/Share
|
|
Dec 29
2022
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
3,232
-0.6%
|
$35,552
$11.07 P/Share
|
|
Dec 29
2022
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
893
-1.64%
|
$9,823
$11.07 P/Share
|
|
Dec 29
2022
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,617
-0.59%
|
$17,787
$11.07 P/Share
|
|
Dec 29
2022
|
Shelly Pinto Interim CFO |
SELL
Open market or private sale
|
Direct |
482
-0.77%
|
$5,302
$11.07 P/Share
|
|
Dec 16
2022
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
46,474
+5.64%
|
$139,422
$3.6 P/Share
|
|
Aug 05
2022
|
Jaume Pons PRESIDENT & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
74,000
+11.99%
|
-
|
|
Aug 05
2022
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
29,000
+34.45%
|
-
|